Henlius’ Trastuzumab Approved In China

Becomes First China-Developed mAb Biosimilar Approved In Both China And EU

 
• By David Wallace
  
Chinese - EU flags
Henlius’ trastuzumab biosimilar has been approved in both China and the EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products